Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co--led by investment funds managed by BlackRock and Eclipse, ...

The global stem cell manufacturing market size was valued at USD 15.83 billion in 2025 and is predicted to hit around USD ...

SOUTH SAN FRANCISCO, Calif. & LONDON--(BUSINESS WIRE)--Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation ...

LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...

Opportunities include the growing demand for scalable solutions to support the burgeoning cell and gene therapy pipeline, ...

Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...

Earlier this week, integrated development and manufacturing organization (IDMO) Cellares announced the closing of its latest ...

Cellular Origins, Resolution Therapeutics, and Cell and Gene Therapy Catapult (CGT Catapult) say they set up a project aimed at using novel technologies to deliver a hyper-efficient, fully automated, ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Techne, bioMerieux, Roche, Lonza Group, Miltenyi Biotec India and More Cell and Gene Therapy Manufacturing QC Market Cell and ...

A team of scientists have developed a simple method for automated manufacturing of lung organoids which could revolutionize the development of treatments for lung disease. These organoids, miniature ...